ANAPHYLAXIS Flashcards
MANAGEMENT
A - STRIDOR.
Fiberoptic awake intubation preferred
Prepare for Cricothyroidotomy
B - RESPIRATORY RATE. >/ 30, 02 sats 90% on Fi02 30%. Work of breathing.
Bronchodilators PRN
C - MOTTLED APPEARANCE. GCS. Pallor. Cap Refill. Distal Pulses. Palpate Abdomen.
D - CHECK GLUCOSE. GCS, PERRLA, lateralizing signs
E - LIMIT FURTHER EXPOSURE,
INITIAL MANAGEMENT
- EPINEPHRINE: INTRAMUSCULAR
> 50 kg: 0.5 mg IM Anteriorlateral Thigh (0.5 mL of 1:1000)
Children >30 kg 0.3 mg IM Anteriorlateral Thigh (0.3 mL of 1:1000)
Children 15-30 kg 0.15 mg IM Anteriorlateral Thigh
Children < 15 kg 0.01 mg / kg / dose (max 0.15 mg) IM Anteriorlateral Thigh
Repeat q 5 min PRN
If > 2-3 IM Epinephrine Doses or Severe Hypotension or Refractory Anaphylaxis, progress to Epinephrine Infusion
- EPINEPHRINE: INFUSION
ANAPHYLAXIS: INFUSION
Weight-Based:
0.01-0.1 μg/kg/minute titrated by 0.01-0.05 μg/kg/minute every 2-3 minutes (1 mg / 1000 ml NS = 1 mcg / mL)
Fixed Dose:
Start at 5 mcg / min (5 mL / min) titrate to effect
OR
Bolus ONLY ADULTS 20-50 up to 100 ug (1 ml of 1:1000 Epi in 10 mL of NS) (0.1 mg/10ml) IV over 5 min to 10 min (cardiac monitoring required)
- FLUID
ADULT DOSING:
30 mL / kg isotonic solution
Pediatric Dosing:
10 to 20 mL/kg isotonic solution
- ANTI-HISTAMINE
Diphenhydramine 50mg IV/PO (pediatric dose, 2 mg / kg) q 4-6 hr x 48-96 hrs (max 400mg/24hr) – this may sedate you patient
OR
Cetirizine (Reactine) 10-20mg PO q12-24hr; slow pharmacokinetics vs. rapidity of anaphylaxis
Ranitidine 50 mg IV (pediatric dose, 0.5 mg / kg) / 150 mg PO in addition may help pruritis
- STEROIDS
ADULT DOSING:
Methylprednisolone 125 mg IV
PEDIATRIC DOSING
Methylprednisolone 2 mg / kg IV
- BETA AGONIST
Salbutamol 2.5 mg nebulized - GLUCAGON
For BetaBlockers with refractory hypotension
Adult dosing: 1-5 mg IV followed by 5-15 ug/min
Pediatric dosing: 20-30 ug/min (max 1 mg) followed by 5-15 ug / min
- ECMO
Refractory to all treatments
DOCUMENTATION
CRITERIA ONE
Acute onset of an illness (minutes to several hours) with involvement of the skin, mucosal tissue, or both (eg, generalized hives, pruritus or flushing, swollen lips-tongue-uvula)
AND AT LEAST ONE OF THE FOLLOWING:
A. Respiratory compromise (eg, dyspnea, wheeze-bronchospasm, stridor, hypoxemia)
B. Reduced BP* or associated symptoms of end-organ dysfunction (eg, hypotonia, collapse, syncope, incontinence)
CRITERIA TWO
TWO OR MORE OF THE FOLLOWING that occur rapidly after exposure to a LIKELY allergen for that patient (minutes to several hours):
A. Involvement of the skin mucosal tissue (eg, generalized hives, itch-flush, swollen lips-tongue-uvula)
B. Respiratory compromise (eg, dyspnea, wheeze-bronchospasm, stridor, hypoxemia)
C. Reduced BP* or associated symptoms (eg, hypotonia, collapse, syncope, incontinence)
D. Persistent gastrointestinal symptoms (eg, crampy abdominal pain, vomiting)
CRITERIA THREE
Reduced BP* after exposure to a KNOWN allergen for that patient (minutes to several hours):
A. Infants and children - Low systolic BP (age-specific)* or greater
than 30% decrease in systolic BP
B. Adults - Systolic BP of less than 90 mmHg or greater than 30% decrease from that person’s baseline
DDx
Allergic (Histamine Mediated) Angioedema
Non-allergic (Bradykinin Mediated) Angioedema
Anaphylaxis
Trauma / Hematoma
Foreign Body
Peritonsilar Abscess
Retropharyngeal Abscess
Epiglotitis
Superior Vena Cava Syndrome
PENICILLIN ALLERGY
FAST
0 of:
Five years since last reaction
Anaphylaxis
Severe cutaneous reaction
Treatment required
<1 % chance of allergy